Artcline

BIO-THERAPIES

Rostock, Germany · Founded 2007

Headquarters
Rostock
Founded
2007
Business Model
B2B
Last Round
Venture RoundSep 2026
Rounds
3

About

ARTCLINE develops ARTICE®, a novel immune cell-based extracorporeal sepsis therapy for patients and medical practitioners worldwide. The therapy uses immune cells from healthy donors to temporarily take over disrupted patient immune-cell functions, remove inflammatory substances from plasma, and support regeneration of the patient's immune system. The company is conducting a controlled randomized multicenter study in Germany for final clinical validation of ARTICE®.

Summary

Artcline is a Biotech company based in Rostock, Germany, founded in 2007. Its most recent funding was a Venture Round in Sep 2026.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundSep 2026

Sign up to see all 3 events

Funding: Venture Round. Amounts, valuations, and investors where available.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Artcline on Indexed.vc
<a href="https://indexed.vc/companies/artcline"><img src="https://indexed.vc/api/badge/company/artcline" alt="Artcline on Indexed.vc" width="260" height="76" /></a>